Modest correlation between IVUS and FFR in intermediate lesions assessment

Original title: FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study Reference: Ron Waksman et al. J Am Coll Cardiol 2013. Article in Press

For patients with angiographically assessed intermediate lesions such as stenosis between 40% and 80%, criteria that favor revascularization remains under debate. 

Fractional Flow Reserve (FFR) is considered the gold standard to assess intermediate lesions, and ≤ 0.8 is considered a significative value. Intravascular ultrasound has traditionally used a 4 mm2 cut-off minimum lumen area (MLA) to classify a lesion as severe; however, this cut-off IVUS value has not been proved equivalent to the functional parameter of FFR.

This prospective, multicenter registry designed to determine the correlation between FFR, IVUS and virtual histology (VH) in intermediate lesions included 350 patients (367 intermediate lesions). Whether to perform an angioplasty procedure or not was the operator’s decision.

ROC analysis identified the 3.07 mm2 global MLA cut-off by IVUS as the best threshold to indentify <0.8 FFR lesions (64% sensitivity, 64% specificity). This global MLA cut-off changes according to the vessel’s reference diameter. For vessels < 3.0 mm in diameter, MLA is <2.4 mm2, vessels between 3.0 and 3.5 mm, MLA = <2.7 mm2 and vessels >3.5 mm, MLA = <3.6 mm2. With these optimal MLA cut-offs by IVUS, taking FFR as gold standard, false positives reached 25.7%. A plaque burden of 68.7 ± 11.2% was the only HV variable which correlated with a <0.8 FFR.

Conclusion 

Anatomical measurement by intravascular ultrasound has a moderate correlation with FFR and depends on the reference diameter.

Comment 

The therapeutic decision for an intermediate lesion should be taken, firstly, following clinical criteria, since both techniques present limitations. IVUS may be a better tool to guide the strategy and monitor the final outcome of an angioplasty procedure, rather than to decide whether to perform it or not.

SOLACI.ORG

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...